Results 81 to 90 of about 96,549 (135)

Abstracts

Molecular Oncology, Volume 20, Issue S1, Page 1-692, August 2026.
Abstracts submitted to the ‘EACR 2026 Congress: Innovative Cancer Science’, from 08–11 June 2026 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source

Management of arsenic trioxide necrosis in the maxilla

, 2004
Historically, pulp-necrotizing agents were commonly used in endodontic treatments. They act quickly and devitalize the pulp within a few days. However, they are cytotoxic to gingiva and bone.
GARİP, HASAN
core   +2 more sources

Immunomodulatory Activity of Methanolic Extract of Carica papaya Leaf on Biochemical Markers and Serum Level of IL-1â in Breast Cancer-Induced Wistar Rats

Sokoto Journal of Medical Laboratory Science
The kidneys are crucial for eliminating toxins, but exposure to substances like arsenic can damage them. Arsenic trioxide, used in cancer treatment, is nephrotoxic.
Imafidon, E.*, Ofojebe, C.S.
doaj   +1 more source

Arsenic Trioxide Modulates DNA Synthesis and Apoptosis in Lung Carcinoma Cells

, 2010
Arsenic trioxide, the trade name Trisenox, is a drug used to treat acute promyleocytic leukemia (APL). Studies have demonstrated that arsenic trioxide slows cancer cells growth.
Tchounwou, Ndebele, Stevens, Walker
core   +1 more source

Formulation Of Oral Compositions Comprising Arsenic Trioxide And Methods Of Use Thereof [PDF]

, 2009
The Present Invention Provides An Oral Formulation Of Arsenic Trioxide (As2o3) For The Treatment Of A Variety Of Hematological Malignancies, Including Acute Myeloid Leukemia (Aml) And Acute Promyelocytic Leukemia (Apl).

core  

Effects of Ethanolic Leaves Extract of Irvingia gabonensis on Arsenic Trioxide-Induced Liver damage in Wistar rats

Journal of Applied Sciences and Environmental Management
The toxicity of drugs and other related agents attracts considerable attention from basic scientists to clinicians. Humankind has been passionate about the availability of cheap and readily available agent against organotoxicity.
S. B. Olukayode, S. O. Innih
doaj  

Formulation of oral compositions comprising arsenic trioxide and methods of use thereof [PDF]

, 2004
The present invention provides an oral formulation of arsenic trioxide (As2O3) for the treatment of a variety of hematological malignancies, including acute myeloid leukemia (AML) and acute promyelocytic leukemia (APL).

core  

Complete Atrioventricular Block after Arsenic Trioxide Treatment in an Acute Promyelocytic Leukemic Patient

, 2009
AV block after arsenic trioxide (As2O3) treatment for refractory acute promyelocytic leukemia is very rare, In this patient, the block was at A-H level and manifested with complete AV block and Wenckebach second-degree type 3:2 block.
黃建華;陳文鍾;吳造中;李源德, HUANG, CHIEN-HUA;CHEN, WEN-JONE;WU, CHAU-CHUNG;LEE, YUAN-THE   +1 more
core   +1 more source

The effect of arsenic trioxide on acute megakaryocytic leukemia : signaling, cell cycle arrest, and apoptosis. [PDF]

, 2004
Lam Kin Bong Hubert.Thesis (M.Phil.)--Chinese University of Hong Kong, 2004.Includes bibliographical references (leaves 139-161).Abstracts in English and Chinese.Abstract (in English) --- p.i(in chinese) --- p.ivAcknowledgements --- p.viPublications --

core  

In the war against solid tumors arsenic trioxide needs partners

, 2014
In the past decade, the therapeutic potential of arsenic trioxide (ATO) in the treatment of acute promyelocytic leukemia (APL) was recognized. This encouraged other investigators to test the efficacy of ATO in the management of other hematological and ...
Ardalan, Bach, Subbarayan, Pochi R
core   +1 more source